Citigroup Adds $7M in Agilent Technologies, Inc. ($A)
Citigroup added 53,124 shares of Agilent Technologies, boosting its stake to 342,286 shares valued at $47.1 million.
Key Points
- Citigroup increased its stake in Agilent Technologies by 18.4%, adding 53,124 shares to reach a total of 342,286 shares worth $47.1 million.
- Shares of Agilent Technologies traded near $137.58 on Friday, with a market cap of $38.3 billion and a P/E ratio of 27.2.
- Insiders at Agilent Technologies have been active, with recent sales and purchases, while analysts maintain a positive outlook with a consensus 'buy' rating.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Citigroup boosted its stake in Agilent Technologies, Inc. (NYSE: A) by 18.4%, according to its latest Form 13F filing with the SEC. The filing, which reflects holdings as of March 31, 2026, shows Citigroup added 53,124 shares, bringing its total to 342,286 shares valued at approximately $47.1 million.
Citigroup vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Citigroup's Agilent Technologies Position
Citigroup's latest move increased its holdings in Agilent Technologies from 289,162 shares to 342,286 shares, an 18.4% rise. The total value of these shares, based on the filing, is about $47.1 million.
Other Institutional Activity in Agilent Technologies
Several other institutional investors also adjusted their positions in Agilent Technologies. BlackRock, Inc. increased its holdings by 33,738 shares, ending with 25,902,662 shares valued at roughly $2.95 billion. Vanguard Capital Management LLC opened a new position with 18,381,030 shares worth about $2.10 billion. Similarly, Vanguard Portfolio Management LLC initiated a stake, acquiring 14,352,682 shares valued at approximately $1.64 billion. Meanwhile, State Street Corp added 82,840 shares, bringing its total to 12,764,632 shares valued at $1.46 billion. Conversely, Massachusetts Financial Services Co /MA/ reduced its holdings by 1,523,511 shares, now holding 12,624,090 shares valued at $1.47 billion.
Agilent Technologies, Inc. Stock Down 13.5%
Shares of Agilent Technologies traded near $137.58 on Friday. The company, with a market cap of $38.3 billion, has a P/E ratio of 27.2 and a forward P/E of 20.5. Its beta is 1.256, indicating a slightly higher volatility than the market. Over the past 52 weeks, the stock has ranged from $108.35 to $160.27, with a 50-day moving average of $122.18 and a 200-day moving average of $130.49. The company maintains a current ratio of 2.10 and a quick ratio of 1.46, with a debt-to-equity ratio of 49.73.
$A stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Agilent Technologies reported revenue of $7.23 billion, reflecting a growth of 0.1%. The company's net margin stands at 19.6%, with a return on equity of 21.3%. Earnings per share (EPS) came in at $4.99. The next earnings release is scheduled for August 26, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
5 target cuts vs 1 raises.
-
EPS & revenue
EPS beat estimates by 3.8%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 4 percent. Operating income missed by 7 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 upgrade, 1 target raise, 5 target cuts.
-
Earnings quality
Gross margin up 3.1 points. Operating margin up 3.8 points. Positive free cash flow.
Earnings Call Summary
Agilent delivered a strong second quarter with $1.83 billion in revenue, up 6.3 percent core growth and beating guidance by 80 basis points. Earnings per share came in at $1.49, beating expectations by 7 cents and growing 14 percent year over year. Operating margin expanded 130 basis points to 26.4 percent, well ahead of guidance. The company is seeing robust momentum across its instrument business with double digit growth in LC LCMS and GC driven by replacement cycles and share gains. Diagnostics grew 11 percent led by the Omnis family and cancer offerings. Strategic pricing delivered over 200 basis points of contribution, exceeding the annual target of 100 basis points at midyear. Management credited the Ignite operating system for driving execution excellence and structural improvements.
Guidance Management raised full year revenue and earnings guidance. The company now expects $7.39 to $7.49 billion in annual revenue with core growth of 4.5 to 6.0 percent, up 30 basis points from prior guidance. Earnings per share guidance increased to $6.00 to $6.10, up 8 cents at the midpoint. For the third quarter, they forecast $1.83 to $1.85 billion in revenue with EPS of $1.48 to $1.50.
Clearly negative report. The company missed important expectations and likely triggers downward revisions.
Dividend
Agilent Technologies pays an annual dividend rate of $1.02, yielding 0.75% with a payout ratio of 20.2%.
Insider Buying and Selling at Agilent Technologies, Inc.
Recent insider activity at Agilent Technologies includes several transactions. On June 3, 2026, CEO Padraig McDonnell sold 418 shares at an average price of $137.40. On May 29, 2026, Mikael Dolsten sold 1,600 shares at $135.42. Conversely, Senior Vice President Michael Steven Buckner acquired 8,872 shares on May 19, 2026. Earlier in March, both Simon May and Koh Boon Hwee sold shares, while Judy Brown purchased 2,158 shares.
Analysts Set New Price Targets
Analyst activity around Agilent Technologies has been positive. On June 11, 2026, Piper Sandler initiated coverage with a 'hold' rating and a $150 price target. On June 3, 2026, HSBC maintained a 'buy' rating with a $165 target. B of A Securities and RBC Capital both maintained 'buy' ratings with targets of $155 on earlier dates. The consensus recommendation for Agilent Technologies is a 'buy', with an average target price of $160.65 from 17 analyst opinions.
About Agilent Technologies
Agilent Technologies, Inc., headquartered in Santa Clara, California, provides application-focused solutions to life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. Led by CEO Mr. Padraig McDonnell, Agilent employs about 18,000 people and offers a wide range of products and services, including chromatography, mass spectrometry systems, and laboratory supplies.
Bottom Line
Citigroup's recent increase in its Agilent Technologies stake is part of a broader institutional interest in the company, as reflected in the latest 13F filings. Agilent's stock performance and financial metrics indicate a stable position within its sector. Investors will be watching upcoming earnings and analyst ratings for further insights, while insider trading activity provides additional context on internal sentiment.
Get Agilent Technologies, Inc. alerts
New 13F filings, insider trades, and analyst moves on $A, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.